The explosion of innovation has the potential to change the face of medicine, improving lives along the way. Speakers traced the path of new medications from discovery in the laboratory to successful commercialization by private-sector companies to life-saving treatment in health care settings. Mr. Bagger,V.P. of Celgene Corp., addressed the committee and emphasized the value of pharmaceutical research and development to the overall U.S. economy. Dr. Jensen, director of the KU Cancer Center, discussed the role a small recurring state budget line item played in helping the Center achieve its National Cancer Insititute designation.